Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2007007105) USE OF 3,1IB-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF SYMPTONS OF HUNTINGTON' S DISEASE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2007/007105 International Application No.: PCT/GB2006/002593
Publication Date: 18.01.2007 International Filing Date: 13.07.2006
IPC:
A61K 31/473 (2006.01) ,A61P 25/14 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
47
Quinolines; Isoquinolines
473
ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
14
for treating abnormal movements, e.g. chorea, dyskinesia
Applicants:
CAMBRIDGE LABORATORIES (IRELAND) LIMITED [IE/IE]; Alexandra House The Sweepstakes Ballsbridge Dublin, 4, IE (AllExceptUS)
TRIDGETT, Robert [GB/GB]; GB (UsOnly)
FILLOUX, Thierry [CH/CH]; CH (UsOnly)
Inventors:
TRIDGETT, Robert; GB
FILLOUX, Thierry; CH
Agent:
HUTCHINS, Michael, Richard; M.R. Hutchins & Co. 23 Mount Sion Tunbridge Wells Kent TN1 1TZ, GB
Priority Data:
0514501.614.07.2005GB
Title (EN) USE OF 3,1IB-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF SYMPTONS OF HUNTINGTON' S DISEASE
(FR) COMPOSES PHARMACEUTIQUES
Abstract:
(EN) The invention provides 3,1 lb-cis-dihydrotetrabenazine for use in halting or slowing the progress of one or more symptoms of Huntington's disease in a patient, and more particularly a symptom selected from involuntary movements such as involuntary chorea, tremors and twitches, and degeneration in gait.
(FR) La présente invention concerne 3,1 lb-cis-dihydrotétrabenazine destiné à stopper ou ralentir la progression d'un ou de plusieurs symptômes de la maladie de Huntington chez un patient, et plus particulièrement un symptôme sélectionné parmi les mouvements involontaires tels que la chorée involontaires, les frayeurs et les secousses ainsi que la dégénération de la démarche.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
RSP-2008/0492MXMX/a/2008/000533KR1020080030666EP1885363EP2027861ZA2008/00905
JP2009501202US20080319000CN101282726CA2615077PT1885363NZ565522
AU2006268098DK1885363